Low PE stocks, often regarded as value stocks, are typically favoured for long-term investment strategies. According to Trendlyne data, SBI, LIC, Infosys, HCL Tech, and L&T are currently trading at lower PE ratios compared to their respective industry averages. Despite belonging to different sectors, these stocks have the potential to rally by up to 13%, as suggested by Trendlyne data.
Getty Images
Brokers have set an average target price of Rs 880 on SBI Life, signalling an upside of 6% from the current market prices. The PE of the stock is at 10.8, while the industry PE is at 15.
ETMarkets.com
Brokers have set an average target price of Rs 1,089 on Life Insurance Corporation (LIC), indicating an upside potential of 6% from the current market prices. The PE of the stock is at 16.15, while the industry PE is at 83.1.
ETMarkets.com
4/9
Infosys | CMP: Rs 1,465
The average target price of Infosys set by the brokers is Rs 1,593, which shows an upside potential of 9% from the current market prices. The PE of the stock is at 23.19, while the industry PE is at 30.3.
Agencies
5/9
Hindustan Unilever | CMP: Rs 2,369
The brokers have set an average target price of Rs 2,548 on Hindustan Unilever (HUL), indicating an upside of 8% from the current market prices. The PE of the stock is at 54.1, while the industry PE is at 55.2.
IANS
The brokers have set an average target price of Rs 3,911 on L&T, implying an upside of 8% from the current market prices. The PE of the stock is at 39.03, while the industry PE is at 39.5.
7/9
HCL Technologies | CMP: Rs 1,345
The average target price of HCL Technologies from brokers is Rs 1,518, signalling an upside of 13% from the current market prices. The PE of the stock is at 23.25, while the industry PE is at 30.3.
iStock
8/9
Axis Bank | CMP: Rs 1,174
The brokers have set an average target price of Rs 1,296 on Axis Bank, indicating an upside of 10% from the current market prices. The PE of the stock is at 13.74, while the industry PE is at 15.
ETMarkets.com
9/9
Sun Pharma | CMP: Rs 1,486
The brokers have set an average target price of Rs 1,592 on Sun Pharma, indicating an upside of 7% from the current market prices. The PE of the stock is at 37.25, while the industry PE is at 40.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Omprakash Tiwary is a business writer who delves into the intricacies of the corporate world. With a focus on finance and economic landscape. He offers readers valuable insights into market trends, entrepreneurship, and economic developments.
Denial of responsibility!Samachar Central is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
